300966.SZ · 共同药业
China A-shares · RS rating 78 · As of 2026-10-14
| Price | 24.01 CNY |
|---|---|
| 1-day change | -2.4% |
| RS rating (overall / 1M / 3M / 12M) | 78 / 83 / 23 / 79 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 36 / 33 / 11 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +13.8% |
| Distance from 52-week high | +22.7% |
| Market cap (USD) | $426.7M |